VENUS CONCEPT INC (VERO)

US92332W2044 - Common Stock

0.3205  0 (-0.68%)

VENUS CONCEPT INC

NASDAQ:VERO (12/23/2024, 4:30:01 PM)

0.3205

0 (-0.68%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS SubIndustryHealth Care Equipment
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%21.95%
Sales Q2Q%-14.81%
CRS2.3
6 Month-59.04%
Overview
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)N/A N/A
Ins Owners2.55%
Inst Owners25.41%
Market Cap2.33M
Shares7.26M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts47.5
Short Float %1.53%
Short Ratio0.09
IPO10-12 2017-10-12
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

VERO Daily chart

Company Profile

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. The company is headquartered in Toronto, Ontario and currently employs 304 full-time employees. The company went IPO on 2017-10-12. The firm develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and 10 direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.

Company Info

VENUS CONCEPT INC

235 Yorkland Blvd Suite 900

TORONTO ONTARIO M2J 4Y8

P: 18778488430

CEO: Domenic Serafino

Employees: 304

Website: https://www.venusconcept.com/en-uk/

VERO News

News Imagea month ago - Venus Concept Inc.Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results

TORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

News Image2 months ago - Venus Concept Inc.Venus Concept Announces Expansion of International Distribution Network and Certification of Products in India

Enhances future international growth profile with new partners and regulatory certifications in key global aesthetic markets...

News Image3 months ago - Venus Concept Inc.Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024

TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

News Image3 months ago - Venus Concept Inc.Venus Concept Announces $15 million Debt-to-Equity Exchange Transaction

Second Substantial Reduction of Existing Debt by Madryn Asset Management in 2024; the Company has reduced its debt balance by 54% year-to-date...

News Image3 months ago - Venus Concept Inc.Venus Concept Announces Australian Regulatory Approval for Venus Bliss MAX

TORONTO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

News Image4 months ago - InvestorPlaceVERO Stock Earnings: Venus Concept Beats EPS, Misses Revenue for Q2 2024

VERO stock results show that Venus Concept beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

VERO Twits

Here you can normally see the latest stock twits on VERO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example